BNP PARIBAS FINANCIAL MARKETS - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 21.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2015$72,884,000
-48.7%
61,766
-15.2%
0.00%
Q2 2015$141,997,000
-8.8%
72,819
-16.8%
0.00%
Q1 2015$155,750,000
-30.4%
87,500
-28.0%
0.00%
-100.0%
Q4 2014$223,663,000
-55.7%
121,556
-41.8%
0.00%
Q3 2014$505,054,000
+8.4%
208,700
+63.4%
0.00%
Q2 2014$466,109,000
-31.8%
127,701
-24.3%
0.00%
-100.0%
Q1 2014$683,464,000
-45.3%
168,698
-47.4%
0.00%
Q4 2013$1,248,690,000
+129.7%
321,000
+167.5%
0.00%
Q3 2013$543,600,000120,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Zhang Financial LLC 45,000$36,0000.02%
A.R.T. Advisors, LLC 381,955$319,0000.02%
Virtu KCG Holdings LLC 705,907$591,0000.02%
OXFORD ASSET MANAGEMENT LLP 687,796$576,0000.01%
ETF MANAGERS GROUP, LLC 89,813$73,0000.01%
FEDERATED HERMES, INC. 1,945,682$1,630,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$272,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$253,0000.00%
WEDBUSH SECURITIES INC 23,000$19,0000.00%
Renaissance Technologies 2,300,800$1,927,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders